APA (7th ed.) Citation

Lin, L., Lu, C., & Tsui, K. (2026). Clarifying IVIG Dosing Regimen Recommendations in the 2025 ASRI Guidelines for Recurrent Pregnancy Loss. American Journal of Reproductive Immunology, 95(5), 1. https://doi.org/10.1111/aji.70245

Chicago Style (17th ed.) Citation

Lin, Li‐Te, Chun‐Chi Lu, and Kuan‐Hao Tsui. "Clarifying IVIG Dosing Regimen Recommendations in the 2025 ASRI Guidelines for Recurrent Pregnancy Loss." American Journal of Reproductive Immunology 95, no. 5 (2026): 1. https://doi.org/10.1111/aji.70245.

MLA (9th ed.) Citation

Lin, Li‐Te, et al. "Clarifying IVIG Dosing Regimen Recommendations in the 2025 ASRI Guidelines for Recurrent Pregnancy Loss." American Journal of Reproductive Immunology, vol. 95, no. 5, 2026, p. 1, https://doi.org/10.1111/aji.70245.